Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Cash from Operations (2017 - 2025)

Catheter Precision (VTAK) has disclosed Cash from Operations for 9 consecutive years, with 2184000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Cash from Operations rose 21.1% to 2184000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was 9677000.0, a 16.65% decrease, with the full-year FY2024 number at 9300000.0, up 54.9% from a year prior.
  • Cash from Operations was 2184000.0 for Q3 2025 at Catheter Precision, up from 2262000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 1697000.0 in Q2 2024 to a low of 12053000.0 in Q1 2023.
  • A 5-year average of 4573473.68 and a median of 3025000.0 in 2022 define the central range for Cash from Operations.
  • Biggest YoY gain for Cash from Operations was 83.89% in 2024; the steepest drop was 53.15% in 2024.
  • Catheter Precision's Cash from Operations stood at 5711000.0 in 2021, then surged by 47.03% to 3025000.0 in 2022, then soared by 37.55% to 1889000.0 in 2023, then tumbled by 53.15% to 2893000.0 in 2024, then rose by 24.51% to 2184000.0 in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Cash from Operations are 2184000.0 (Q3 2025), 2262000.0 (Q2 2025), and 2338000.0 (Q1 2025).